関節リウマチ(Rheumatoid Arthritis)治療薬の世界市場予測および分析...市場調査レポートについてご紹介

【英文タイトル】PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis to 2023

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 10
1.1 List of Tables 17
1.2 List of Figures 25
2 Introduction 28
2.1 Catalyst 28
2.2 Related Reports 29
2.3 Upcoming Related Reports 29
3 Disease Overview 30
3.1 Etiology and Pathophysiology 30
3.1.1 Etiology 30
3.1.2 Pathophysiology 30
3.2 Symptoms 35
3.3 Prognosis 36
3.4 Quality of Life 36
4 Epidemiology 37
4.1 Disease Background 37
4.2 Risk Factors and Comorbidities 37
4.3 Global Trends 39
4.3.1 US 39
4.3.2 5EU 40
4.3.3 Japan 41
4.3.4 Australia 41
4.3.5 China 42
4.3.6 India 42
4.4 Forecast Methodology 42
4.4.1 Sources Used 45
4.4.2 Sources Not Used 49
4.4.3 Forecast Assumptions and Methods – Total Prevalent Cases of RA 50
4.4.4 Forecast Assumptions and Methods – Diagnosed Prevalent Cases of RA 54
4.5 Epidemiological Forecast for RA (2013-2023) 55
4.5.1 Total Prevalent Cases of RA 55
4.5.2 Age-Specific Total Prevalent Cases of RA 57
4.5.3 Sex-Specific Total Prevalent Cases of RA 59
4.5.4 Diagnosed Prevalent Cases of RA 61
4.5.5 Age-Standardized Diagnosed Prevalence of RA 63
4.6 Discussion 65
4.6.1 Epidemiological Forecast Insight 65
4.6.2 Limitations of the Analysis 65
4.6.3 Strengths of the Analysis 66
5 Disease Management 67
5.1 Diagnosis and Treatment Overview 67
5.1.1 Diagnosis 67
5.1.2 Treatment Guidelines 69
5.1.3 Leading Prescribed Drugs for the Treatment of RA 78
5.1.4 Clinical Practice 79
5.2 US 84
5.3 France 88
5.4 Germany 89
5.5 Italy 92
5.6 Spain 94
5.7 UK 95
5.8 Japan 99
5.9 Australia 101
5.10 China 103
5.11 India 105
6 Competitive Assessment 108
6.1 Overview 108
6.2 Product Profiles – Major Brands 109
6.2.1 Enbrel (etanercept) 109
6.2.2 Humira (adalimumab) 116
6.2.3 Remicade (infliximab) 120
6.2.4 Simponi (golimumab) 126
6.2.5 Cimzia (certolizumab pegol) 132
6.2.6 Orencia (abatacept) 136
6.2.7 Actemra/RoActemra (tocilizumab) 142
6.2.8 Rituxan/MabThera (rituximab) 150
6.2.9 Inflectra/Remsima (infliximab biosimilar) 155
6.2.10 Xeljanz (tofacitinib) 158
6.2.11 Iguratimod/T-614 165
6.2.12 Methotrexate (Numerous Brands) 169
6.3 Biosimilars 172
6.3.1 Introduction 172
6.3.2 Hospira’s Inflectra Versus J&J’s Remicade in Key Autoimmune Diseases 174
6.3.3 Biosimilars in the Immunology Community 174
6.3.4 By the Numbers: Biosimilars in Development 175
6.3.5 The Impact of Biosimilars Will be Felt Throughout the Pharmaceutical Industry 179
6.3.6 Uptake of Biosimilars for RA is Expected to Vary by Market 180
6.3.7 Biosimilars’ Forecast 183
6.4 Other Therapies 191
7 Unmet Need and Opportunity 193
7.1 Overview 193
7.2 Development of Cost-Effective Therapies 194
7.2.1 Unmet Need 194
7.2.2 Gap Analysis 195
7.2.3 Opportunity 195
7.3 Biomarkers to Predict Responsiveness to Therapy 196
7.3.1 Unmet Need 196
7.3.2 Gap Analysis 198
7.3.3 Opportunity 198
7.4 Early Diagnosis of RA 199
7.4.1 Unmet Need 199
7.4.2 Gap Analysis 200
7.4.3 Opportunity 201
7.5 Personalized Treatment Approach 202
7.5.1 Unmet Need 202
7.5.2 Gap Analysis 202
7.5.3 Opportunity 204
8 Pipeline Assessment 206
8.1 Overview 206
8.2 Clinical Trial Mapping 206
8.2.1 Clinical Trials by Class 206
8.3 Promising Drugs in Clinical Development 208
8.3.1 Sarilumab 215
8.3.2 Sirukumab 223
8.3.3 Clazakizumab 230
8.3.4 Cosentyx (secukinumab) 236
8.3.5 Tregalizumab 242
8.3.6 Mavrilimumab 248
8.3.7 Denosumab (Prolia/Xgeva) 253
8.3.8 Baricitinib 259
8.3.9 Peficitinib 269
8.3.10 Decernotinib 275
8.3.11 Filgotinib 281
8.3.12 Masitinib 287
8.3.13 RAVAX 294
8.4 Other Drugs in Development 299
9 Current and Future Players 302
9.1 Trends in Corporate Strategy 305
9.2 Company Profiles 306
9.2.1 AbbVie 306
9.2.2 Pfizer 308
9.2.3 Amgen 311
9.2.4 Johnson & Johnson 314
9.2.5 Eli Lilly 316
9.2.6 Bristol-Myers Squibb 318
9.2.7 UCB 320
9.2.8 Roche 321
9.2.9 GlaxoSmithKline 323
9.2.10 Novartis 325
9.2.11 Sanofi 327
9.2.12 AstraZeneca- MedImmune 329
9.2.13 Astellas 331
9.2.14 Vertex 333
9.2.15 Daiichi Sankyo 335
10 Market Outlook 338
10.1 Global Markets 338
10.1.1 Forecast 338
10.1.2 Drivers and Barriers – Global Issues 343
10.2 United States 345
10.2.1 Forecast 345
10.2.2 Key Events 351
10.2.3 Drivers and Barriers 352
10.3 France 354
10.3.1 Forecast 354
10.3.2 Key Events 359
10.3.3 Drivers and Barriers 359
10.4 Germany 362
10.4.1 Forecast 362
10.4.2 Key Events 367
10.4.3 Drivers and Barriers 368
10.5 Italy 371
10.5.1 Forecast 371
10.5.2 Key Events 376
10.5.3 Drivers and Barriers 376
10.6 Spain 378
10.6.1 Forecast 378
10.6.2 Key Events 384
10.6.3 Drivers and Barriers 385
10.7 United Kingdom 387
10.7.1 Forecast 387
10.7.2 Key Events 393
10.7.3 Drivers and Barriers 393
10.8 Japan 396
10.8.1 Forecast 396
10.8.2 Key Events 401
10.8.3 Drivers and Barriers 401
10.9 Australia 404
10.9.1 Forecast 404
10.9.2 Key Events 409
10.9.3 10.9.3 Drivers and Barriers 409
10.10 China 411
10.10.1 Forecast 411
10.10.2 Key Events 416
10.10.3 Drivers and Barriers 416
10.11 India 418
10.11.1 Forecast 418
10.11.2 Key Events 423
10.11.3 Drivers and Barriers 423
11 Appendix 426
11.1 Bibliography 426
11.2 Abbreviations 452
11.3 Methodology 459
11.4 Forecasting Methodology 459
11.4.1 Diagnosed RA Patients 459
11.4.2 Percentage of Drug-Treated Patients 460
11.4.3 Drugs Included in Each Therapeutic Class 460
11.4.4 Launch and Patent Expiry Dates 461
11.4.5 General Pricing Assumptions 462
11.4.6 Individual Drug Assumptions 464
11.4.7 Generic and Biosimilar Erosion 476
11.4.8 Pricing of Pipeline Agents 476
11.5 Primary Research – KOLs Interviewed for This Report 479
11.6 Primary Research – Prescriber Survey 481
11.7 About the Authors 481
11.7.1 Analyst 481
11.7.2 Reviewer 482
11.7.3 Therapy Area Director 482
11.7.4 Epidemiologist 483
11.7.5 Global Head of Healthcare 484
11.8 About GlobalData 485
11.9 Disclaimer 485


【レポート販売概要】

■ タイトル:関節リウマチ(Rheumatoid Arthritis)治療薬の世界市場予測および分析
■ 英文:PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis to 2023
■ 発行日:2014年12月31日
■ 調査会社:GlobalData
■ 商品コード:GDHC93PIDR
■ 調査対象地域:グローバル
  • 免疫グロブリン(Ig)製品の世界市場2016-2020
    About Immunoglobulin Products Immunoglobulins, also known as antibodies, are proteins that help neutralize foreign objects such as bacteria and viruses. They help recognize and bind to particular antigens. Based on the difference in the amino acid sequence in the fragment crystallizable (Fc) region of the antibody heavy chain, they can be categorized into the following isotypes: IgA, IgD, IgE, IgG …
  • 世界のジメトエート市場2015
    The Global Dimethoate Industry Report 2015 is a professional and in-depth study on the current state of the Dimethoate industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Dimethoate market analysis is provided for the international markets including development trends, competitive landscape analysis, a …
  • Apache Corporation社の石油・ガス開発・生産動向及びコスト分析(2013年第4四半期)
    Apache Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2013 Summary Apache Corporation (Apache) is an upstream energy company. The company carries out exploration, development and production of natural gas, crude oil and natural gas liquids (NGLs). Apache has operations in the US, Canada, Egypt, the UK, North Sea, Australia and Argentina. As of December 2013, th …
  • A2A SpA:発電所及びSWOT分析2013
    A2A SpA - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - summarized and detailed in …
  • Tekelec LTE Drives Opportunities in Diameter, Policy and Subscriber Management
    Tekelec has transformed its legacy signaling business in TDM networks to become a leading independent provider of? Next Generation Network (NGN) signaling, control, and OSS.? This report evaluates the current and future prospects for Tekelec including financials, competitors, and qualitative analysis.? ? The report analyzes the future of the Core Diameter, Policy Management, and Subscriber Managem …
  • 世界の次世代シーケンシング(NGS)市場:製品別(NOVASEQ、NEXTSEQ、SEQUEL、NANOPORE)、消耗品別、バイオインフォマティクス別、サービス別(EXOME、RNA、DENOVO)、技術別(ION、SMRT)、 用途別(診断、がん)、エンドユーザー別、地域別
    “The global NGS market is projected to grow at a CAGR of 20.9% during the forecast period.” The next-generation sequencing (NGS) market is projected to reach USD 24.4 billion by 2025 from USD 7.8 billion in 2019, at a CAGR of 20.9%. The growth of this market is largely driven by advancements in and the declining costs of NGS platforms and the improving regulatory and reimbursement scenario for NGS …
  • 世界のレベルセンサー市場2015
    The Global Level Sensors Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Level Sensors industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Level Sensors market analysis is provided for the international markets including development trends, competit …
  • アセトニトリルの世界市場2018-2022
    About Acetonitrile Acetonitrile is a simple organic nitrile with chemical formula CH3CN. It is a colorless liquid and is obtained as a byproduct during acrylonitrile manufacturing process. Technavio’s analysts forecast the global acetonitrile market to grow at a CAGR of 4.94% during the period 2018-2022. Covered in this report The report covers the present scenario and the growth prospects of the …
  • 股関節置換:企業と競争環境
    MediPoint: Total Hip Replacement - Current and Future Players Summary GlobalData has released its medical devices report, “MediPoint: Total Hip Replacement - Current and Future Players”. The report is an essential source of information and analysis on the global total hip replacement market. The mature market in the design of hip replacement products has led to a shift in the focus of developing o …
  • 電子戦(EW)の世界市場:電子戦支援、電子攻撃、電子防護
    The market size of the electronic market (EW) market is estimated to be valued at USD 20.55 Billion in 2016 and is projected to grow at a CAGR of 4.29% during the forecast period, to reach USD 25.36 Billion by 2021. The market demand is projected to be driven by ongoing technological advancements in the electronic warfare systems, which would improve the performance and efficiency aspect of these …
  • 無人水上艦(USV)の世界市場予測(~2022年)
    “Increasing need for ISR, water quality monitoring and data mapping is a major factor for increasing procurement of Unmanned Surface Vehicle (USV), globally”The unmanned surface vehicle market is expected to grow from USD 470.1 million in 2017 to USD 938.5 million by 2022 at a CAGR of 14.83% from 2017 to 2022. The market for unmanned surface vehicles is driven by factors, such as increasing need f …
  • LED照明安定器の世界市場2016-2020
    About LED Lamps LED lamps and luminaires use external ballasts, which are broadly categorized into two main types of external LED drivers: • Constant-current drivers • Constant-voltage drivers Constant-current drivers are used where lighting system requires fixed output current with varying range of output voltages. The range of voltage depends on the on the load (wattage) of the LED. Constant-vol …
  • MES(製造実行システム)の世界市場2015-2019
    About MES MES acts as a means of communication between various divisions and helps in decision making by providing enterprise-wide records. The manufacturing industry uses MES automation software to improve operational performance by automating, executing, and managing manufacturing operations, such as scheduling, tracking, resource allocation and control, plant maintenance, labor planning, data a …
  • ヒト胚性幹細胞(hESC)の世界市場分析:用途別(再生医療、幹細胞生物学研究、組織工学、毒物学検査)、国別(アメリカ、イギリス、ドイツ、日本、中国)、セグメント予測、2014-2025
    The global human embryonic stem cells (hESCs) market is anticipated to reach USD 1.06 billion by 2025, according to a new report by Grand View Research, Inc. Application of hESCs as a promising donor source for cellular transplantation therapies is anticipated to bolster progress through to 2025. hESCs technology tends to be useful for tissue engineering in humans due to high histocompatibility be …
  • 石油・ガス採揚作業用工具の世界市場2015-2019
    Covering: This market research provides a detailed analysis and segmentation of the global oil and gas fishing tools market by tool type (internal & external catching, milling tools, jarring assemblies, junk baskets, accessories, remedial and repair, washover, drillpipe and casing cutters, safety joints, and reverse units and power swivels), by application (onshore and offshore), and by geography …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。